We previously reported that treatment with various GSK-3β inhibitors (AR-A014418, SB-216763, TDZD-8, and 9-ING-41) inhibited proliferation and induced cell cycle arrest in RCC cells [38,39,40,56]. The gene discussed is GSK3B; the disease is renal cell carcinoma.